1-9 of 9
Liping Lan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Promising Safety and Efficacy of Trovocabtagene Autoleucel (C-CAR088) Followed ASCT in Ultra High-Risk Multiple Myeloma (UHR-MM) Patients

Yan Xu, Wensi Li, Gang An, Weiwei Sui, Shuhui Deng, Tingyu Wang, Shuhua Yi, Qi Wang, Rui Lyu, Xiong Wenjie, Chenxing Du, Wei Liu, Wenyang Huang, Judy Zhu, Jiaqi Huang, Chengxiao Zheng, Liping Lan, Kevin Zhu, Lugui Qiu, Dehui Zou
Journal: Blood
Blood (2024) 144 (Supplement 1): 7236.
https://doi.org/10.1182/blood-2024-197883
Published: 2024
Journal Articles

A Phase Ib/II Study of Trovocabtagene Autoleucel (C-CAR088), an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

Gang An, Yan Xu, Shuhua Yi, Rui Lyu, Jiaqi Huang, Wensi Li, Yiran Zhang, Liping Lan, Lugui Qiu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7235.
https://doi.org/10.1182/blood-2024-194774
Published: 2024
Journal Articles

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Ping Li, Wen-Juan Yu, Lili Zhou, Min Yang, Shiguang Ye, Judy Zhu, Jiaqi Huang, Yan Zhang, Lanfang Li, Jing Zhao, Kevin Zhu, Jing Li, Chengxiao Zheng, Liping Lan, Hui Wan, Yihong Yao, Huilai Zhang, Daobin Zhou, Jie Jin, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1025.
https://doi.org/10.1182/blood-2023-182817
Published: 2023
Journal Articles

Promising Safety and Efficacy of Trovocabtagene Autoleucel (C-CAR088) Followed ASCT in Ultra High-Risk Multiple Myeloma (UHR-MM) Patients Who Failed or Had Suboptimal Response to Standard First Line Triplet Based Therapy

Yan Xu, Wensi Li, Gang An, Weiwei Sui, Shuhui Deng, Tingyu Wang, Shuhua Yi, Wenyang Huang, Wei Liu, Qi Wang, Rui Lv, Wenjie Xiong, Chenxing Du, Judy Zhu, Jiaqi Huang, Chengxiao Zheng, Liping Lan, Kevin Zhu, Lugui Qiu, Dehui Zou
Journal: Blood
Blood (2023) 142 (Supplement 1): 6864.
https://doi.org/10.1182/blood-2023-184868
Published: 2023
Journal Articles

Updated Phase 1 Results of C-CAR088, an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma

Xiaoyan Qu, Gang An, Weiwei Sui, Tingyu Wang, Xian Zhang, Junfang Yang, Yan Zhang, Lu Zhang, Judy Zhu, Jiaqi Huang, Jing Li, Shirley Zheng, Kevin Zhu, Liping Lan, Shiyi Chen, Michael Humphries, Yihong Yao, Daobin Zhou, Peihua LU, Lugui Qiu, Jianyong Li
Journal: Blood
Blood (2021) 138 (Supplement 1): 1830.
https://doi.org/10.1182/blood-2021-150037
Published: 2021
Journal Articles

An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma

Gang An, MD PhD, Weiwei Sui, MD, Tingyu Wang, Xiaoyan Qu, MD PhD, Xian Zhang, MD, Junfang Yang, Yan Zhang, MD, Lu Zhang, MD, Judy Zhu, MD, Chengxiao Zheng, MD, Xiuxiu Yan, Xiaoteng Lv, MS, Liping Lan, MS, Dingzhu Yang, Ningning Huo, Ting Han, MS, Dijun Zhao, MS, Shichao Qin, Junfeng Wu, PhD, Xin Yao, PhD, Shigui Zhu, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Jiaqi Huang, PhD, Michael Humphries, MD, Yihong Yao, PhD, Daobin Zhou, MD PhD, Jianyong Li, MD PhD, Peihua Lu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-138734
Published: 2020
Journal Articles

Developing a Novel Anti-CD19/CD20 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Relapsed/Refractory (r/r) B-Cell NHL

Lili Zhou, MD, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Shiguang Ye, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Yanfeng Li, MS, Liping Lan, MS, Shicheng Chen, Lin Guo, PhD, Qingsong Zhang, MS, Jiangqin Zheng, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-137826
Published: 2020
Journal Articles

Early Clinical Results of a Novel Anti-CD20 Chimeric Antigen Receptor (CAR)-T Cell Therapy for B-Cell NHL Patients Who Are Relapsed/Resistant Following CD19 CAR-T Therapy

Shiguang Ye, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Lili Zhou, MD, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Liping Lan, MS, Shicheng Chen, Yutian Wei, MS, Wangqin Shu, MS, Chen Ye, Dan Zhang, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-138538
Published: 2020
Journal Articles

Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma

Xin Yao, PhD, Shigui Zhu, PhD, Jiaqi Huang, PhD, Xiaoyan Qu, MD PhD, Judy Zhu, MD, Yutian Wei, MS, Liping Lan, MS, Xiaoteng LV, MS, Junfeng Wu, PhD, Rirfei Wang, MS, Dingzhu Yang, Chengxiao Zheng, MD, DiJun Zhao, MS, Lei Fan, MD PhD, Fei Huang, Hua Lu, MD PhD, Chaocan Zhang, MS, Cheng Chen, PhD, Yanfeng Li, MS, Jiaqiang Ren, MD PhD, Li Zhang, MD, Michael Humphries, MD, Jianyong Li, MD, Yihong Yao, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 50.
https://doi.org/10.1182/blood-2019-125372
Published: 2019